Deals of the Week, December 25 to 1– Growth Business roundup 1 Jan 2021
Our final Deals of the Week of the year and our first of the new one, listing seed funding, venture capital and crowdfunding deals of note.
Fitness brand looks to reach upper echelons after Goldman Sachs backing
Echelon Fitness, the connected home fitness brand that offers products linked via app, has completed a $65m (£47.5m) financing led by Goldman Sachs Growth, with participation from existing investor North Castle Partners.
Piper Sandler acted as exclusive financial advisor to Echelon Fitness, overseeing the deal.
The capital will help Echelon expand its market share and range of products.
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission.
2020 has indeed brought forth unforeseen challenges into the world due to the global coronavirus pandemic. However, this year has also seen monumental victories for psychedelic medicine–a radical new hope for a brighter future. The current state of mental healthcare, which has been starkly exposed due to the pandemic, is seriously insufficient.There is a significant need for new and better mental health treatments now more than ever before.
Fortunately, between the groundbreaking clinical research into psychedelic medicine at leading universities and institutions and the
MagicMed Industries Inc. (CSE: MGIC reserved) (
MagicMed or the
Company ) announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the Psybrary
TM and the launch of the Candidate Selection program. The Psybrary
TM is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, manufacturing methods, pharmacological data, and patent filings that protect all of the above.
MagicMed s Chief Scientific Officer, Dr. Peter Facchini, stated Our psilocybin-derivatives portfolio, which also captures dimethyltryptamine (DMT) derivatives, now includes 12 filed patent applications directed to 9 different chemical compound categories covering over 125 million individual molecules. While we certainly don t expect to synthesize all of these molecules during the development of new drug candidates, I am pleased to announce that, as of today s launch of the Candidate Selection program, we have alre
MagicMed Industries gibt Einrichtung eines Psilocybin-Derivate-Portfolios und Start eines Kandidatenauswahlprogramms bekannt finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.